Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2018

Open Access 01-12-2018 | Research

Diabetic retinopathy among Brazilian Xavante Indians

Authors: Carlos Gustavo M. G. Lima, Laercio Joel Franco, Amaury L. Dal Fabbro, Edson Z. Martinez, João Paulo Botelho Veira-Filho, Alexandre A. C. M. Ventura, Leonardo Prevelato, Antonio Augusto V. Cruz

Published in: Diabetology & Metabolic Syndrome | Issue 1/2018

Login to get access

Abstract

Background

To describe the frequency of diabetic retinopathy (DR) and its associated variables in Brazilian Xavante Indians.

Methods

A population-based survey carried out in two Xavante Reservations between 2008 and 2012, included 948 Indians aged 20 years or more, identified 246 individuals with type 2 diabetes. A non-probabilistic cluster sample of 140 diabetic individuals were submitted to ophthalmologic examination. Due to operational conditions and to optimize the field work, only the larger Xavante villages were included. Ophthalmologic examinations were performed during one trip to each reservation, in their villages and consisted of measurement visual acuity, anterior segment biomicroscopy, applanation tonometry, and direct and indirect ophthalmoscopy.

Results

The frequency of DR was 19.3%, distributed as follows: mild non-proliferative retinopathy in nine (33.3%) subjects, moderate in nine (33.3%), severe in six (22.3%), very severe in two (7.4%), and high-risk proliferative DR in one (3.7%). The occurrence of DR was higher among those with a longer duration of diabetes, higher levels of glycated hemoglobin (HbA1c) and fasting glucose, papillary excavation ≥ 0.5, and among individuals in older age group. Using the log-binomial regression model, diabetes duration > 24 months and HbA1c ≥ 6.5% were significantly associated with the occurrence of DR.

Conclusions

The presence of DR (19.3%) in Xavante Indians is an alert for health care providers for this population, since diabetes is a new disease among them. Its association with disease duration, high levels of HbA1c and blood glucose calls attention for the necessity of more actions to improve diabetes control in this recently contacted ethnic group that needs particular attention.
Literature
2.
go back to reference Naqshbandi M, Harris SB, Esler JG, Antwi-Nsiah F. Global complication rates of type 2 diabetes in Indigenous peoples: a comprehensive review. Diabetes Res Clin Pract. 2008;82:1–17.CrossRefPubMed Naqshbandi M, Harris SB, Esler JG, Antwi-Nsiah F. Global complication rates of type 2 diabetes in Indigenous peoples: a comprehensive review. Diabetes Res Clin Pract. 2008;82:1–17.CrossRefPubMed
3.
go back to reference Yu CH, Zinman B. Type 2 diabetes and impaired glucose tolerance in aboriginal populations: a global perspective. Diabetes Res Clin Pract. 2007;78:159–70.CrossRefPubMed Yu CH, Zinman B. Type 2 diabetes and impaired glucose tolerance in aboriginal populations: a global perspective. Diabetes Res Clin Pract. 2007;78:159–70.CrossRefPubMed
4.
go back to reference Kuhn PC, Horimoto AR, Sanches JM, Vieira Filho JP, Franco L, Fabbro AD, et al. Genome-wide analysis in Brazilian Xavante Indians reveals low degree of admixture. PLoS ONE. 2012;7:e42702.CrossRefPubMedPubMedCentral Kuhn PC, Horimoto AR, Sanches JM, Vieira Filho JP, Franco L, Fabbro AD, et al. Genome-wide analysis in Brazilian Xavante Indians reveals low degree of admixture. PLoS ONE. 2012;7:e42702.CrossRefPubMedPubMedCentral
5.
go back to reference Lima CGMG. Saúde ocular em índios Xavante portadores de diabetes mellitus tipo 2 [Doctoral thesis]: São Paulo University; 2015. Lima CGMG. Saúde ocular em índios Xavante portadores de diabetes mellitus tipo 2 [Doctoral thesis]: São Paulo University; 2015.
7.
go back to reference Pereira NOM, Santos RV, Welch JR, Souza LG, Coimbra CE Jr. Demography, territory, and identity of indigenous peoples in Brazil: the Xavante indians and the 2000 Brazilian National Census. Hum Org. 2009;68:166–80.CrossRef Pereira NOM, Santos RV, Welch JR, Souza LG, Coimbra CE Jr. Demography, territory, and identity of indigenous peoples in Brazil: the Xavante indians and the 2000 Brazilian National Census. Hum Org. 2009;68:166–80.CrossRef
8.
go back to reference Arantes R, Santos RV, Coimbra Jr CEA. Saúde bucal na população indígena Xavánte de Pimentel Barbosa, Mato Grosso, Brasil. Cad Saúde Pública. 2001;17:375–84.CrossRefPubMed Arantes R, Santos RV, Coimbra Jr CEA. Saúde bucal na população indígena Xavánte de Pimentel Barbosa, Mato Grosso, Brasil. Cad Saúde Pública. 2001;17:375–84.CrossRefPubMed
9.
go back to reference Coimbra CE Jr, Flowers NM, Salzano FM, Santos RV. The Xavánte in transition: health, ecology and bioanthropology in Central Brazil. Ann Arbor: University of Michigan Press; 2002.CrossRef Coimbra CE Jr, Flowers NM, Salzano FM, Santos RV. The Xavánte in transition: health, ecology and bioanthropology in Central Brazil. Ann Arbor: University of Michigan Press; 2002.CrossRef
10.
go back to reference Vieira Filho JP. Emergência do diabetes melito tipo II entre os Xavantes. Rev Ass Med Brasil. 1996;42:61. Vieira Filho JP. Emergência do diabetes melito tipo II entre os Xavantes. Rev Ass Med Brasil. 1996;42:61.
11.
go back to reference Vieira Filho JP, Franco LJ. Prevalência de diabetes mellitus em índios Xavante de Sangradouro-MT. Arq Bras Endocrinol Metabol. 2007;51:S492. Vieira Filho JP, Franco LJ. Prevalência de diabetes mellitus em índios Xavante de Sangradouro-MT. Arq Bras Endocrinol Metabol. 2007;51:S492.
12.
go back to reference Dal Fabbro AL, Franco LJ, da Silva AS, Sartorelli DS, Soares LP, Franco LF, et al. High prevalence of type 2 diabetes mellitus in Xavante Indians from Mato Grosso, Brazil. Ethn Dis. 2014;24:35–40. Dal Fabbro AL, Franco LJ, da Silva AS, Sartorelli DS, Soares LP, Franco LF, et al. High prevalence of type 2 diabetes mellitus in Xavante Indians from Mato Grosso, Brazil. Ethn Dis. 2014;24:35–40.
13.
go back to reference World Health Organization. World Health Organization definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. WHO/NCS/99.2. Geneva: WHO; 1999. World Health Organization. World Health Organization definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. WHO/NCS/99.2. Geneva: WHO; 1999.
14.
go back to reference Gautier JF, Milner MR, Elam E. Visceral adipose tissue is not increased in Pima Indians compared with equally obese Caucasians and is not related to insulin action or secretion. Diabetologia. 1999;42:28–34.CrossRefPubMed Gautier JF, Milner MR, Elam E. Visceral adipose tissue is not increased in Pima Indians compared with equally obese Caucasians and is not related to insulin action or secretion. Diabetologia. 1999;42:28–34.CrossRefPubMed
15.
go back to reference Lear SA, Humphries KH, Kohli S. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr. 2007;86:353–9.CrossRefPubMed Lear SA, Humphries KH, Kohli S. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr. 2007;86:353–9.CrossRefPubMed
16.
go back to reference Lear SA, Humphries KH, Frohlich JJ. Appropriateness of current thresholds for obesity-related measures among Aboriginal people. Can Med Assoc J. 2007;177:1499–505.CrossRef Lear SA, Humphries KH, Frohlich JJ. Appropriateness of current thresholds for obesity-related measures among Aboriginal people. Can Med Assoc J. 2007;177:1499–505.CrossRef
17.
go back to reference Chalmers J. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Guidelines subcommittee. J Hypertens. 1999;17:151–83. Chalmers J. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Guidelines subcommittee. J Hypertens. 1999;17:151–83.
19.
go back to reference Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology. 1991;98:823–33.CrossRef Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology. 1991;98:823–33.CrossRef
20.
22.
go back to reference Yeung RO, Zhang Y, Luk A, Yang W, Sobrepena L, Yoon KH, et al. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol. 2014;2:935–43.CrossRefPubMed Yeung RO, Zhang Y, Luk A, Yang W, Sobrepena L, Yoon KH, et al. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol. 2014;2:935–43.CrossRefPubMed
23.
go back to reference Song SH, Gray TA. Early-onset type 2 diabetes: high risk for premature diabetic retinopathy. Diabetes Res Clin Pract. 2011;94:207–11.CrossRefPubMed Song SH, Gray TA. Early-onset type 2 diabetes: high risk for premature diabetic retinopathy. Diabetes Res Clin Pract. 2011;94:207–11.CrossRefPubMed
24.
go back to reference Fong DS, Aiello LP, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care. 2004;27:2540–53.CrossRefPubMed Fong DS, Aiello LP, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care. 2004;27:2540–53.CrossRefPubMed
25.
go back to reference Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991;98:786–806.CrossRef Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991;98:786–806.CrossRef
26.
go back to reference Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–64.CrossRefPubMedPubMedCentral Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–64.CrossRefPubMedPubMedCentral
27.
go back to reference Escarião PHG, Arantes TEF, Filho NCF, Urtiga RD, Florêncio TLT, Arcoverde ALAL. Epidemiologia e diferenças regionais da retinopatia diabética em Pernambuco. Brasil Arq Bras Oftalmol. 2008;71:172–5.PubMed Escarião PHG, Arantes TEF, Filho NCF, Urtiga RD, Florêncio TLT, Arcoverde ALAL. Epidemiologia e diferenças regionais da retinopatia diabética em Pernambuco. Brasil Arq Bras Oftalmol. 2008;71:172–5.PubMed
28.
go back to reference Garcia CAA, Gomes AHB, Nunes IM, Oliveira TL, Monteiro J. Diabetic retinopathy incidence and risk factors in patients of the Onofre Lopes University Hospital, Natal—RN. Arq Bras Oftalmol. 2003;66:355–8.CrossRef Garcia CAA, Gomes AHB, Nunes IM, Oliveira TL, Monteiro J. Diabetic retinopathy incidence and risk factors in patients of the Onofre Lopes University Hospital, Natal—RN. Arq Bras Oftalmol. 2003;66:355–8.CrossRef
29.
go back to reference Guedes MF, Portes AJF, Couto AF Jr, Nunes JS, Oliveira RCC. Prevalência da retinopatia diabética em unidade do programa de saúde da família. Rev Bras Oftalmol. 2009;68:90–5.CrossRef Guedes MF, Portes AJF, Couto AF Jr, Nunes JS, Oliveira RCC. Prevalência da retinopatia diabética em unidade do programa de saúde da família. Rev Bras Oftalmol. 2009;68:90–5.CrossRef
30.
go back to reference Jost BS, Hilgemberg E, Rodrigues EB, Daniotti AF. Bonamigo EL [Prevalence of diabetic retinopathy in patients affected by type 2 diabetes mellitus in the city of Luzerna–SC. Arq Bras Oftalmol. 2010;73:259–65.CrossRefPubMed Jost BS, Hilgemberg E, Rodrigues EB, Daniotti AF. Bonamigo EL [Prevalence of diabetic retinopathy in patients affected by type 2 diabetes mellitus in the city of Luzerna–SC. Arq Bras Oftalmol. 2010;73:259–65.CrossRefPubMed
31.
go back to reference Drummond KRG, Malerbi FK, Morales PH, Mattos TCL, Pinheiro AA, Mallmann F, et al. Regional dfferences in the prevalence of diabetic retinopathy: a multi center study in Brazil. Diabetol Metab Syndr. 2018;10:1–11.CrossRef Drummond KRG, Malerbi FK, Morales PH, Mattos TCL, Pinheiro AA, Mallmann F, et al. Regional dfferences in the prevalence of diabetic retinopathy: a multi center study in Brazil. Diabetol Metab Syndr. 2018;10:1–11.CrossRef
32.
go back to reference Berinstein DM, Stahn RM, Welty TK, Leonardson GR, Herlihy JJ. The prevalence of diabetic retinopathy and associated risk factors among Sioux Indians. Diabetes Care. 1997;20:757–9.CrossRefPubMed Berinstein DM, Stahn RM, Welty TK, Leonardson GR, Herlihy JJ. The prevalence of diabetic retinopathy and associated risk factors among Sioux Indians. Diabetes Care. 1997;20:757–9.CrossRefPubMed
33.
go back to reference Farrell MA, Quiggins PA, Eller JD, Owle PA, Miner KM, Walkingstick ES. Prevalence of diabetes and its complications in the Eastern Band of Cherokee Indians. Diabetes Care. 1993;16:253–6.CrossRefPubMed Farrell MA, Quiggins PA, Eller JD, Owle PA, Miner KM, Walkingstick ES. Prevalence of diabetes and its complications in the Eastern Band of Cherokee Indians. Diabetes Care. 1993;16:253–6.CrossRefPubMed
34.
go back to reference Ross SA, McKenna A, Mozejko S, Fick GH. Diabetic retinopathy in native and nonnative Canadians. Exp Diabetes Res. 2007;2007:76271.CrossRefPubMed Ross SA, McKenna A, Mozejko S, Fick GH. Diabetic retinopathy in native and nonnative Canadians. Exp Diabetes Res. 2007;2007:76271.CrossRefPubMed
35.
go back to reference Maberley D, Walker H, Koushik A, Cruess A. Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis. CMAJ. 2003;168:160–4.PubMedPubMedCentral Maberley D, Walker H, Koushik A, Cruess A. Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis. CMAJ. 2003;168:160–4.PubMedPubMedCentral
36.
go back to reference Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, Berg K, Chakravarthy U, Gerendas BS, et al. Guidelines for the management of diabetic macular edema by the european society of retina specialists (EURETINA). Ophthalmologica. 2017;237:185–222.CrossRefPubMed Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, Berg K, Chakravarthy U, Gerendas BS, et al. Guidelines for the management of diabetic macular edema by the european society of retina specialists (EURETINA). Ophthalmologica. 2017;237:185–222.CrossRefPubMed
37.
go back to reference Kulberg CE, Arnqvist HJ. Good blood glucose control characterizes patients without retinopathy after long diabetes duration. Diabet Med. 1994;12:314–20.CrossRef Kulberg CE, Arnqvist HJ. Good blood glucose control characterizes patients without retinopathy after long diabetes duration. Diabet Med. 1994;12:314–20.CrossRef
38.
go back to reference Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44:968–83.CrossRef Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44:968–83.CrossRef
39.
go back to reference Cheng YJ, Gregg EW, Geiss LS, Imperatore G, Williams DE, Zhang X, et al. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: implications for diabetes diagnostic thresholds. Diabetes Care. 2009;32:2027–32.CrossRefPubMedPubMedCentral Cheng YJ, Gregg EW, Geiss LS, Imperatore G, Williams DE, Zhang X, et al. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: implications for diabetes diagnostic thresholds. Diabetes Care. 2009;32:2027–32.CrossRefPubMedPubMedCentral
40.
go back to reference Frank RN, Hoffman WH, Podgor MJ, Joondeph HC, Lewis RA, Margherio RR, et al. Retinopathy in juvenile-onset type I diabetes of short duration. Diabetes. 1982;31:874–82.CrossRefPubMed Frank RN, Hoffman WH, Podgor MJ, Joondeph HC, Lewis RA, Margherio RR, et al. Retinopathy in juvenile-onset type I diabetes of short duration. Diabetes. 1982;31:874–82.CrossRefPubMed
41.
go back to reference Fong DS, Ferris FL 3rd, Davis MD, Chew EY. Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group. Am J Ophthalmol. 1999;127:137–41.CrossRefPubMed Fong DS, Ferris FL 3rd, Davis MD, Chew EY. Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group. Am J Ophthalmol. 1999;127:137–41.CrossRefPubMed
42.
go back to reference Michelessi M, Lucenteforte E, Oddone F, Brazzelli M, Parravano M, Franchi S, et al. Optic nerve head and fibre layer imaging for diagnosing glaucoma. Cochrane Database Syst Rev. 2015;11:CD008803.PubMedCentral Michelessi M, Lucenteforte E, Oddone F, Brazzelli M, Parravano M, Franchi S, et al. Optic nerve head and fibre layer imaging for diagnosing glaucoma. Cochrane Database Syst Rev. 2015;11:CD008803.PubMedCentral
43.
go back to reference Reus NJ, Lemij HG, Garway-Heath DF, Airaksinen PJ, Anton A, Bron AM, et al. Clinical assessment of stereoscopic optic disc photographs for glaucoma: the European Optic Disc Assessment Trial. Ophthalmology. 2010;117:717–23.CrossRefPubMed Reus NJ, Lemij HG, Garway-Heath DF, Airaksinen PJ, Anton A, Bron AM, et al. Clinical assessment of stereoscopic optic disc photographs for glaucoma: the European Optic Disc Assessment Trial. Ophthalmology. 2010;117:717–23.CrossRefPubMed
44.
go back to reference Chopra V, Varma R, Francis BA, Wu J, Torres M, Azen SP, et al. Type 2 diabetes mellitus and the risk of open-angle glaucoma the Los Angeles Latino Eye Study. Ophthalmology. 2008;115(227–32):e1. Chopra V, Varma R, Francis BA, Wu J, Torres M, Azen SP, et al. Type 2 diabetes mellitus and the risk of open-angle glaucoma the Los Angeles Latino Eye Study. Ophthalmology. 2008;115(227–32):e1.
45.
go back to reference Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye Study. Ophthalmology. 1994;101:1173–7.CrossRefPubMed Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye Study. Ophthalmology. 1994;101:1173–7.CrossRefPubMed
46.
go back to reference Klein BE, Klein R, Moss SE. Intraocular pressure in diabetic persons. Ophthalmology. 1984;91:1356–60.CrossRefPubMed Klein BE, Klein R, Moss SE. Intraocular pressure in diabetic persons. Ophthalmology. 1984;91:1356–60.CrossRefPubMed
47.
go back to reference Zhou M, Wang W, Huang W, Zhang X. Diabetes mellitus as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. PLoS ONE. 2014;9:e102972.CrossRefPubMedPubMedCentral Zhou M, Wang W, Huang W, Zhang X. Diabetes mellitus as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. PLoS ONE. 2014;9:e102972.CrossRefPubMedPubMedCentral
48.
go back to reference Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21:359–93.CrossRefPubMed Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21:359–93.CrossRefPubMed
49.
go back to reference Piltz-seymour JR, Grunwald JE, Hariprasad SM, Dupont J. Optic nerve blood flow is diminished in eyes of primary open-angle glaucoma suspects. Am J Ophthalmol. 2001;132:63–9.CrossRefPubMed Piltz-seymour JR, Grunwald JE, Hariprasad SM, Dupont J. Optic nerve blood flow is diminished in eyes of primary open-angle glaucoma suspects. Am J Ophthalmol. 2001;132:63–9.CrossRefPubMed
50.
go back to reference American Diabetes Association. American diabetes association: treatment of hypertension in adults with diabetes. Diabetes Care. 2002;25:S71–3.CrossRef American Diabetes Association. American diabetes association: treatment of hypertension in adults with diabetes. Diabetes Care. 2002;25:S71–3.CrossRef
51.
go back to reference Passos VMA, Assis TD, Barreto SM. Hypertension in Brazil: estimates from population-based prevalence studies. Epidemiol Serv Saúde. 2006;15:35–45. Passos VMA, Assis TD, Barreto SM. Hypertension in Brazil: estimates from population-based prevalence studies. Epidemiol Serv Saúde. 2006;15:35–45.
52.
go back to reference Bertelsen G, Peto T, Lindekleiv H, Schirmer H, Solbu MD, Toft I, et al. Sex differences in risk factors for retinopathy in non-diabetic men and women: the Tromso Eye Study. Acta Ophthalmol. 2014;92:316–22.CrossRefPubMed Bertelsen G, Peto T, Lindekleiv H, Schirmer H, Solbu MD, Toft I, et al. Sex differences in risk factors for retinopathy in non-diabetic men and women: the Tromso Eye Study. Acta Ophthalmol. 2014;92:316–22.CrossRefPubMed
53.
go back to reference Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology. 1998;105:1801–15.CrossRefPubMed Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology. 1998;105:1801–15.CrossRefPubMed
54.
go back to reference Moreno A, Lozano M, Salinas P. Diabetic retinopathy. Nutr Hosp. 2013;28(Suppl 2):53–6.PubMed Moreno A, Lozano M, Salinas P. Diabetic retinopathy. Nutr Hosp. 2013;28(Suppl 2):53–6.PubMed
55.
go back to reference Xu J, Wei WB, Yuan MX, Yuan SY, Wan G, Zheng YY, et al. Prevalence and risk factors for diabetic retinopathy: the Beijing communities diabetes study 6. Retina. 2012;32:322–9.CrossRefPubMed Xu J, Wei WB, Yuan MX, Yuan SY, Wan G, Zheng YY, et al. Prevalence and risk factors for diabetic retinopathy: the Beijing communities diabetes study 6. Retina. 2012;32:322–9.CrossRefPubMed
56.
go back to reference Chew EY, Klein ML, Ferris FL 3rd, Remaley NA, Murphy RP, Chantry K, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol. 1996;114:1079–84.CrossRefPubMed Chew EY, Klein ML, Ferris FL 3rd, Remaley NA, Murphy RP, Chantry K, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol. 1996;114:1079–84.CrossRefPubMed
57.
go back to reference Minuto N, Emmanuele V, Vannati M, Russo C, Rebora C, Panarello S, et al. Retinopathy screening in patients with type 1 diabetes diagnosed in young age using a non-mydriatic digital stereoscopic retinal imaging. J Endocrinol Invest. 2012;35:389–94.PubMed Minuto N, Emmanuele V, Vannati M, Russo C, Rebora C, Panarello S, et al. Retinopathy screening in patients with type 1 diabetes diagnosed in young age using a non-mydriatic digital stereoscopic retinal imaging. J Endocrinol Invest. 2012;35:389–94.PubMed
58.
go back to reference Jawa A, Kcomt J, Fonseca VA. Diabetic nephropathy and retinopathy. Med Clin N Am. 2004;88:1001–36.CrossRefPubMed Jawa A, Kcomt J, Fonseca VA. Diabetic nephropathy and retinopathy. Med Clin N Am. 2004;88:1001–36.CrossRefPubMed
59.
go back to reference Klein R. The epidemiology of diabetic retinopathy. Diabet Retinopath. Baltimore: Human Press; 2008. Klein R. The epidemiology of diabetic retinopathy. Diabet Retinopath. Baltimore: Human Press; 2008.
60.
go back to reference Wang J, Zhang RY, Chen RP, Sun J, Yang R, Ke XY, et al. Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population. BMC Public Health. 2013;13:633.CrossRefPubMedPubMedCentral Wang J, Zhang RY, Chen RP, Sun J, Yang R, Ke XY, et al. Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population. BMC Public Health. 2013;13:633.CrossRefPubMedPubMedCentral
Metadata
Title
Diabetic retinopathy among Brazilian Xavante Indians
Authors
Carlos Gustavo M. G. Lima
Laercio Joel Franco
Amaury L. Dal Fabbro
Edson Z. Martinez
João Paulo Botelho Veira-Filho
Alexandre A. C. M. Ventura
Leonardo Prevelato
Antonio Augusto V. Cruz
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2018
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-018-0348-z

Other articles of this Issue 1/2018

Diabetology & Metabolic Syndrome 1/2018 Go to the issue